These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 38397377)

  • 1. Zinc-Dependent Histone Deacetylases in Lung Endothelial Pathobiology.
    Patil RS; Maloney ME; Lucas R; Fulton DJR; Patel V; Bagi Z; Kovacs-Kasa A; Kovacs L; Su Y; Verin AD
    Biomolecules; 2024 Jan; 14(2):. PubMed ID: 38397377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Class IIa HDACs improves endothelial barrier function in endotoxin-induced acute lung injury.
    Kovacs-Kasa A; Kovacs L; Cherian-Shaw M; Patel V; Meadows ML; Fulton DJ; Su Y; Verin AD
    J Cell Physiol; 2021 Apr; 236(4):2893-2905. PubMed ID: 32959895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical Versatility in Catalysis and Inhibition of the Class IIb Histone Deacetylases.
    Christianson DW
    Acc Chem Res; 2024 Apr; 57(8):1135-1148. PubMed ID: 38530703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Histone Deacetylases in Acute Lung Injury-Friend or Foe.
    Luo G; Liu B; Fu T; Liu Y; Li B; Li N; Geng Q
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of an epigenetic signature of early mouse liver regeneration that is disrupted by Zn-HDAC inhibition.
    Huang J; Schriefer AE; Yang W; Cliften PF; Rudnick DA
    Epigenetics; 2014 Nov; 9(11):1521-31. PubMed ID: 25482284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone Deacetylases in Kidney Physiology and Acute Kidney Injury.
    Hyndman KA
    Semin Nephrol; 2020 Mar; 40(2):138-147. PubMed ID: 32303277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibitors of zinc-dependent histone deacetylases. Therapeutic targets relevant to cancer.
    Kollar J; Frecer V
    Curr Pharm Des; 2015; 21(11):1472-502. PubMed ID: 25382430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The important role of histone deacetylases in modulating vascular physiology and arteriosclerosis.
    Zhao TC; Wang Z; Zhao TY
    Atherosclerosis; 2020 Jun; 303():36-42. PubMed ID: 32535412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cigarette Smoke Disrupted Lung Endothelial Barrier Integrity and Increased Susceptibility to Acute Lung Injury via Histone Deacetylase 6.
    Borgas D; Chambers E; Newton J; Ko J; Rivera S; Rounds S; Lu Q
    Am J Respir Cell Mol Biol; 2016 May; 54(5):683-96. PubMed ID: 26452072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of dietary histone deacetylases (HDACs) inhibitors in health and disease.
    Bassett SA; Barnett MP
    Nutrients; 2014 Oct; 6(10):4273-301. PubMed ID: 25322459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase inhibition and the regulation of cell growth with particular reference to liver pathobiology.
    Joanna F; van Grunsven LA; Mathieu V; Sarah S; Sarah D; Karin V; Tamara V; Vera R
    J Cell Mol Med; 2009 Sep; 13(9B):2990-3005. PubMed ID: 19583816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging roles of HDACs and their therapeutic implications in cancer.
    Hai R; Yang D; Zheng F; Wang W; Han X; Bode AM; Luo X
    Eur J Pharmacol; 2022 Sep; 931():175216. PubMed ID: 35988787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitors prevent pulmonary endothelial hyperpermeability and acute lung injury by regulating heat shock protein 90 function.
    Joshi AD; Barabutis N; Birmpas C; Dimitropoulou C; Thangjam G; Cherian-Shaw M; Dennison J; Catravas JD
    Am J Physiol Lung Cell Mol Physiol; 2015 Dec; 309(12):L1410-9. PubMed ID: 26498249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erasers of histone acetylation: the histone deacetylase enzymes.
    Seto E; Yoshida M
    Cold Spring Harb Perspect Biol; 2014 Apr; 6(4):a018713. PubMed ID: 24691964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histones and lung cancer: Are the histone deacetylases a promising therapeutic target?
    Petta V; Gkiozos I; Strimpakos A; Syrigos K
    Cancer Chemother Pharmacol; 2013 Nov; 72(5):935-52. PubMed ID: 24036844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discussion on structure classification and regulation function of histone deacetylase and their inhibitor.
    Han H; Feng X; He T; Wu Y; He T; Yue Z; Zhou W
    Chem Biol Drug Des; 2024 Jan; 103(1):e14366. PubMed ID: 37776270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Histone Deacetylases in Monocyte Function in Health and Chronic Inflammatory Diseases.
    Tordera RM; Cortés-Erice M
    Rev Physiol Biochem Pharmacol; 2021; 180():1-47. PubMed ID: 33974124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of histone deacetylases in vascular cell homeostasis and arteriosclerosis.
    Zhou B; Margariti A; Zeng L; Xu Q
    Cardiovasc Res; 2011 Jun; 90(3):413-20. PubMed ID: 21233251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylases in vascular permeability and remodeling associated with acute lung injury.
    Kovacs L; Kovacs-Kasa A; Verin AD; Fulton D; Lucas R; Su Y
    Vessel Plus; 2018; 2():. PubMed ID: 32099966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDAC 3-selective inhibitor RGFP966 demonstrates anti-inflammatory properties in RAW 264.7 macrophages and mouse precision-cut lung slices by attenuating NF-κB p65 transcriptional activity.
    Leus NG; van der Wouden PE; van den Bosch T; Hooghiemstra WTR; Ourailidou ME; Kistemaker LE; Bischoff R; Gosens R; Haisma HJ; Dekker FJ
    Biochem Pharmacol; 2016 May; 108():58-74. PubMed ID: 26993378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.